Phytochemicals and nanoformulation strategies for rheumatoid arthritis: mechanistic insights, therapeutic advances, and translational challenges
Inflammopharmacology · 2026-01 · 34 (1) · 91-123
DOI: 10.1007/s10787-025-02065-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 08.12.2025. Verfasst von Mohsen Rahmanian und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, 74877-94149, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Phytochemicals, Nanoparticles, Antirheumatic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 291 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease characterized by persistent joint inflammation, cartilage degradation, and systemic complications. Phytochemicals such as curcumin, resveratrol, phenolic acids, flavonoids, lignans, and organosulfur compounds have demonstrated significant disease-modifying potential through modulation of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and key signaling pathways (NF-κB, MAPK, PI3K/AKT/mTOR). Curcumin, for example, regulates immune homeostasis by restoring the Th17/Treg balance and inhibiting NF-κB and mTOR signaling, while resveratrol suppresses angiogenesis via VEGF inhibition and induces apoptosis in fibroblast-like synoviocytes. Despite their pharmacological promise, poor aqueous solubility, rapid metabolism, and low systemic bioavailability limit clinical translation. Advances in nanoformulation technologies-including polymeric nanoparticles, liposomes, micelles, solid lipid nanoparticles, and stimuli-responsive carriers-have markedly improved phytochemical stability, pharmacokinetics, targeted delivery, and therapeutic efficacy. Analytical characterization methods such as dynamic light scattering, zeta potential analysis, FTIR, HPLC, and TEM facilitate precise formulation optimization and evaluation of biological interactions. Preclinical studies reveal that nano-curcumin can achieve efficacy comparable to methotrexate, while resveratrol-loaded gold nanoparticles enhance anti-inflammatory effects and joint-specific accumulation. This review integrates mechanistic insights, formulation strategies, and analytical approaches, highlighting the opportunities and regulatory considerations for translating nano-phytochemicals into clinically viable RA therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, 74877-94149, Iran.
- Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
- Cell Therapy and Regenerative Medicine Innovation Center, North Khorasan University of Medical Sciences, Bojnurd, 74877-94149, Iran. f.oroojalian@gmail.com.
- Department of Medical Nanotechnology, School of Medicine, North Khorasan University of Medical Science, Bojnurd, 74877-94149, Iran. f.oroojalian@gmail.com.
- Department of Physiology, Biochemistry, and Pharmacology, College of Veterinary Medicine, University of Kirkuk, Kirkuk, 36001, Iraq.
- Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, 470003, India. prashantdops@gmail.com.
Zitieren
APA
Rahmanian, M., Khosropanah, S., Moghaddam, S. H., Vatankhah, A., Haghbin, A., Oroojalian, F., Abass, K. S., Kesharwani, P., & Sahebkar, A. (2026). Phytochemicals and nanoformulation strategies for rheumatoid arthritis: mechanistic insights, therapeutic advances, and translational challenges. Inflammopharmacology, 34(1), 91-123. https://doi.org/10.1007/s10787-025-02065-6
Vancouver
Rahmanian M, Khosropanah S, Moghaddam SH, Vatankhah A, Haghbin A, Oroojalian F, et al. Phytochemicals and nanoformulation strategies for rheumatoid arthritis: mechanistic insights, therapeutic advances, and translational challenges. Inflammopharmacology. 2026;34(1):91-123. doi:10.1007/s10787-025-02065-6
BibTeX
@article{Rahmanian2026,
author = {Rahmanian, Mohsen and Khosropanah, Sarah and Moghaddam, Sepehr Hoseinzadeh and Vatankhah, Abulfazl and Haghbin, Ali and Oroojalian, Fatemeh and Abass, Kasim Sakran and Kesharwani, Prashant and Sahebkar, Amirhossein},
title = {Phytochemicals and nanoformulation strategies for rheumatoid arthritis: mechanistic insights, therapeutic advances, and translational challenges},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {1},
pages = {91--123},
doi = {10.1007/s10787-025-02065-6}
}
EUVIMED